|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | |
| C12Q 1/70 | |||
| C12Q 1/04 | |||
| A61K 49/00 | |||
| A61K 49/06 | |||
| A61K 39/395 |
| (11) | Patento numeris | 1863940 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06769770.6 |
| Europos patento paraiškos padavimo data | 2006-02-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-12-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-06-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2006/006723 |
| Data | 2006-02-24 |
| (87) | Numeris | WO 2006/112951 |
| Data | 2006-10-26 |
| (30) | Numeris | Data | Šalis |
| 658335 P | 2005-03-03 | US |
| (72) |
RUBIN, Keith H., US
GLAZER, Steven, US
|
| (73) |
Seedlings Life Science Ventures, LLC.,
770 Broadway 2nd Floor/power Space, New York, NY 10003,
US
|
| (54) | METHOD OF RISK MANAGEMENT FOR PATIENTS UNDERGOING NATALIZUMAB TREATMENT |
| METHOD OF RISK MANAGEMENT FOR PATIENTS UNDERGOING NATALIZUMAB TREATMENT |